# Vitro Biopharma, Inc. — Form D

Vitro Biopharma, Inc. of GOLDEN, CO, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-11. The offering totals $15.0M, of which $100K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-06-11
- Form: D
- Accession: 0001641172-25-014683
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $100K
- Remaining: $14.9M
- Investors: 1
- Date of first sale: 2025-05-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-548679

## Issuer

- Name: Vitro Biopharma, Inc.
- CIK: 0000793171
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 4621 TECHNOLOGY DR., GOLDEN, CO, 80403
- Phone: 866-848-7627

## Officers, directors & promoters (23)

| Name | Role | Location |
| --- | --- | --- |
| Chris Furman | Director | Golden, CO |
| Caroline Mosessian | Director | Golden, CO |
| James Musick | Director | Golden, CO |
| John Packs | Director | Golden, CO |
| Chris Furman | Executive Officer | Golden, CO |
| Thomas Ohrt | Executive Officer | Golden, CO |
| James Musick | Executive Officer | Golden, CO |
| Tiana R States | Executive Officer | Denver, CO |
| Nathan Haas | Executive Officer | Denver, CO |
| Christopher Furman | Director | Denver, CO |
| Christopher Furman | Executive Officer | Denver, CO |
| John R Packs | Director | Denver, CO |
| James R Musick | Director | Denver, CO |
| James R Musick | Executive Officer | Denver, CO |
| Caroline R Mosessian | Director | Denver, CO |
| Caroline R Mosessian | Executive Officer | Denver, CO |
| JACK ZAMORA | Director | DENVER, CO |
| JACK ZAMORA | Executive Officer | DENVER, CO |
| John Evans | Director | West Haven, CT |
| John Evans | Executive Officer | West Haven, CT |
| ERIK D VAN HORN | Director | Golden, CO |
| ERIK D VAN HORN | Executive Officer | Golden, CO |
| ERIK VAN HORN | Director | GOLDEN, CO |

## Other filings by this issuer (8)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-12-01](https://search.stillhousedata.com/formd/0001876512-23-000002) | D | $3.0M | $2.0M |
| [2023-04-05](https://search.stillhousedata.com/formd/0001493152-23-011018) | D/A | $2.5M | $993K |
| [2023-01-23](https://search.stillhousedata.com/formd/0001493152-23-002197) | D | $405K | $405K |
| [2021-10-20](https://search.stillhousedata.com/formd/0001011034-21-000004) | D | $10.0M | $3.0M |
| [2020-10-08](https://search.stillhousedata.com/formd/0001011034-20-000026) | D/A | $3.5M | $1.0M |
| [2020-01-23](https://search.stillhousedata.com/formd/0001011034-20-000003) | D | $1.0M | $500K |
| [2010-09-30](https://search.stillhousedata.com/formd/0000793171-10-000004) | D | $30K | $30K |
| [2010-01-06](https://search.stillhousedata.com/formd/0001011034-10-000004) | D | $88K | $88K |

## More

- [CIK 793171 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=793171&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001641172-25-014683.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.